Free Trial
→ How to invest in Elon Musk’s Optimus before its launch (From InvestorPlace) (Ad) Buy SLN Stock  Free SLN Stock Alerts

Silence Therapeutics (SLN) SEC Filings & 10K Form

Silence Therapeutics logo
$3.94 +0.25 (+6.62%)
As of 11:18 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Silence Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/28/2025
5:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
8:28 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
04/24/2025
6:16 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
9:35 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
1:17 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
6:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:47 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:50 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
03/06/2025
10:03 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:20 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:30 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
9:59 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:03 PM		Redmile Group, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13G
02/11/2025
5:41 PM		Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13G/A
01/02/2025
3:32 PM		HELLUMS RHONDA LYNETTE (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:34 PM		Davidson Michael H. (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:36 PM		Ede-Golightly James (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:38 PM		Ross Iain (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:39 PM		Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
TOOMAN CRAIG A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:43 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
7:00 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:32 PM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
12/09/2024
7:12 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
3:54 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
8:44 AM		Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:24 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
4:20 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form F-3ASR
08/15/2024
8:05 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/02/2024
5:51 PM		Invus Global Management, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
06/27/2024
6:40 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:38 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
7:41 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
1:21 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
11:15 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form EFFECT
05/08/2024
4:14 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form DEL AM
05/01/2024
3:37 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SLN) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners
How to invest in Elon Musk’s Optimus before its launch
Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...
InvestorPlace | Sponsored
This Is How Empires Fall
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored
Is he more powerful than Trump?
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Elon Set to Shock the World by May 1st ?
Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...
Brownstone Research | Sponsored
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Trump and Buffett Are Quietly Leading America’s Gold Revival
The “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...
Golden Portfolio | Sponsored
This isn’t a trade war. It’s worse…
Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...
Stansberry Research | Sponsored
Elon Musk’s next move from the Oval Office?
No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...
Weiss Ratings | Sponsored